A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2011
11/16/2011	CN101524386B Chinese herbal main component prescription for curing fatty liver
11/16/2011	CN101522651B Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents
11/16/2011	CN101516852B Quinoline derivatives with 5-ht-binding properties
11/16/2011	CN101511372B Anti-cancer therapy comprising an h2-blocker, at least one antiinflammatory agent and a cytotoxic agent
11/16/2011	CN101507787B Dietetic medicine preparation capable of promoting lactation and preparation method thereof
11/16/2011	CN101507715B Solid preparation of angiotensin receptor inhibitor and amlodipine and new preparation method thereof
11/16/2011	CN101505731B Compositions comprising calcium citrate malate and methods for making the same
11/16/2011	CN101484428B Alkyl-pyridazine derivatives as inhibitors of 11 beta hydroxysteroid dehydrogenase type 1(11b-HSD 1)
11/16/2011	CN101475554B 1',2',3',7'-tetrahydrotheaflavine-3,3'-digallate, and preparation and use thereof
11/16/2011	CN101474284B External use medicament for treating fungal dermatopathy
11/16/2011	CN101474161B Nicorandil freeze-dried injection and preparation method thereof
11/16/2011	CN101461829B Spikemoss extract, extraction method and application thereof
11/16/2011	CN101448481B O/w emulsion for caring for hands
11/16/2011	CN101429142B Nitrogen-containing polyhydroxy fragrant compounds, preparation and uses thereof
11/16/2011	CN101406474B Nalmefene injection and preparation method thereof
11/16/2011	CN101395168B Galactose derivative,Drug carrier and medicinal composition
11/16/2011	CN101365442B Use of benzo-fused heterocycle sulfamide derivatives for preparing medicine for the treatment of obesity
11/16/2011	CN101365441B Use of benzo-fused heterocycle sulfamide derivatives for preparing medicine for lowering lipids and lowering blood glucose levels
11/16/2011	CN101336955B Gynostemma pentaphylla extract and preparation method thereof and use thereof in preparing medicine for preventing and treating fatty liver and sub-health
11/16/2011	CN101330915B Pharmaceutical compositions containing Erythrine mulungu derivatives and processes for their production
11/16/2011	CN101326169B Glucocorticoid receptor modulators as antiinflammatory agents
11/16/2011	CN101316580B Fexofenadine suspension formulation
11/16/2011	CN101305004B Novel diazabicyclic aryl derivatives and their medical use
11/16/2011	CN101304999B Non-steroidal compounds useful as glucocorticoid receptor modulators
11/16/2011	CN101287457B Use of treprostinil to treat neuropathic diabetic foot ulcers
11/16/2011	CN101223177B Water-soluble arteannuin derivant, production method, medicine composition and usage
11/16/2011	CN101212973B 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
11/16/2011	CN101212968B 3,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo [4,5-d]pyrimidin-2-one compounds and prodrug thereof
11/16/2011	CN101198597B Preparation and use of compounds as aspartyl protease inhibitors
11/16/2011	CN101175487B Pharmaceutical use of ebselen
11/16/2011	CN101175476B Ophthalmic suspension comprising an ophthalmic drug, a poloxamine and a glycol tonicity-adjusting agent, use of said composition for the manufacture of a medicament for treating ophthalmic disorders
11/16/2011	CN101172980B Method for the preparation of hexahydro-furo 2,3-b furan-3-ol
11/16/2011	CN101171234B Dihydropyridine derivatives
11/16/2011	CN101166529B Benzotriazole derivatives as cannabinoid receptor antagonists
11/16/2011	CN101137364B Compositions comprising an epothilone and production methods
11/16/2011	CN101128193B Anti-radical agents
11/16/2011	CN101102989B Substituted cyclopentanes or cyclopentanones for the treatment of ocular hypertensive conditions
11/16/2011	CN101102758B Thyroid hormone analogs for promoting angiogenesis
11/16/2011	CN101087752B Novel ligands that modulate RAR receptors, and use thereof in human medicine and in cosmetics
11/16/2011	CN101084227B Rapamycin analogues and the uses thereof in the treatment of neurological disorders, proliferative diseases and inflammatory disease
11/16/2011	CN101068826B Potent LNA oligonucleotides for the inhibition of HIF-1A expression
11/16/2011	CN101062041B Novel medical function of cucurbitacin
11/16/2011	CN101062040B Stable type cucurbitacin liquid formula and the agent thereof
11/16/2011	CN101043908B Complex containing mequitazine, a cyclodextrin and an interaction agent
11/16/2011	CN101022791B Compositions comprising nebivolol
11/16/2011	CN101010320B Aminotropane derivatives, preparation thereof and therapeutic use thereof
11/16/2011	CN101005846B Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase and an oily phase
11/15/2011	US8060172 In-vivo information measurement apparatus
11/15/2011	US8058476 HCI polymorphs of 3-((2-(dimethylamino)methyl(cyclohex-1-yl)) phenol
11/15/2011	US8058475 Substituted cyclohexylmethyl compounds
11/15/2011	US8058467 Prostaglandin derivatives
11/15/2011	US8058462 Adding ligand then alkalinity agent to metal salt solution; precipitating such as iron hydroxide maleate; micronutrients
11/15/2011	US8058454 Method for preparing 1,3-disubstituted pyrrolidine compounds
11/15/2011	US8058452 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
11/15/2011	US8058446 [5-(Pyridin-2-ylamino)-6-oxo-1,6-dihydro-pyridin-3-yl]-(3-amido)-benzene derivatives; anticarcinogenic, antiproliferative, antiallergen, and antiinflammatory agents; lymphoma, leukemia, autoimmune diseases; Bruton's tyrosine kinase inhibitors
11/15/2011	US8058445 Substituted pyridinecarboxamides for the treatment of cancer
11/15/2011	US8058443 making crystalline lenalidomide
11/15/2011	US8058442 Neuroprotective iron chelators and pharmaceutical compositions comprising them
11/15/2011	US8058441 For control fertility, contraception, breast cancer, prostate cancer and endometriosis; modulating activity of the follicle stimulating hormone (FSH) receptor; 1-Acetyl-6-(tert-butoxycarbonyl)amino-4-phenyl-1,2,3,4-tetrahydro-2,2,4-trimethylquinoline
11/15/2011	US8058437 (Pyrroloquinoxalinyl) pyrazinecarbohydrazide-oxalic acid co-crystal for treatment of cancer and other diseases
11/15/2011	US8058434 Compositions to effect neuronal growth
11/15/2011	US8058430 Biologically active aphrocallistin compounds
11/15/2011	US8058426 Phosphorus-containing compounds and uses thereof
11/15/2011	US8058425 Purine derivatives as kinase inhibitors
11/15/2011	US8058424 Synthesis of 5-azacytidine
11/15/2011	US8058418 Polynucleotides encoding heavy and light chains of antibodies to OPGL
11/15/2011	US8058413 Molecular transporters based on sugar and its analogues and processes for the preparation thereof
11/15/2011	US8058400 Composition and method for modulating dendritic cell-t cell interaction
11/15/2011	US8058344 Glycodendrimers having biological activity
11/15/2011	US8058316 STAT3 inhibiting compositions and methods
11/15/2011	US8058315 Foaming alcohol compositions with selected dimethicone surfactants
11/15/2011	US8058314 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
11/15/2011	US8058313 4-((1E)-2-(((E)-2-fluoro-4-cyanostyrylsulfonyl)methylsulfonyl)vinyl)-3-fluoro-benzonitrile; mitogen activated protein kinase inhibitor; cell growth factor receptor antagonist; angiogenesis inhibitor, antiproliferative and anticarcinogenic agent; neurodegenerative diseases
11/15/2011	US8058312 N, N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same
11/15/2011	US8058311 Imaging 18F or 11C-labelled alkylthiophenyl guanidines
11/15/2011	US8058310 Polyphenol proteasome inhibitors, synthesis, and methods of use
11/15/2011	US8058309 Protein kinase modulators and therapeutic uses thereof
11/15/2011	US8058308 Substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
11/15/2011	US8058307 Alcanoic acid amides substituted by saturated O-heterocycles
11/15/2011	US8058306 Phenyl pyrrole aminoguanidine derivatives
11/15/2011	US8058305 Pyrrolidine derivatives as prostaglandin modulators
11/15/2011	US8058304 Merged ion channel modulating compounds and uses thereof
11/15/2011	US8058303 Pharmaceutical composition for external use
11/15/2011	US8058302 Process for preparing pure anastrozole
11/15/2011	US8058301 Valsartan; hypotensive agents, cardiovascular disorders, anticholesterol agents, antilipemic agents
11/15/2011	US8058300 Polycyclic antagonists of lysophosphatidic acid receptors
11/15/2011	US8058299 Diacylglycerol acyltransferase inhibitors
11/15/2011	US8058297 Compounds for the treatment of proliferative disorders
11/15/2011	US8058296 Treatment and prevention of deleterious effects associated with alcohol consumption
11/15/2011	US8058295 Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof
11/15/2011	US8058294 Pharmaceutical salts of N-[2-(diethylamino)ethyl]-N-(2-{[2-(4-hydroxy-2-oxo-2,3-dihydro-1,3-benzothiazol-7-yl)ethyl]amino}ethyl)-3-[2-(1-napthyl)ethoxy]propanamide
11/15/2011	US8058293 Compounds as cannabinoid receptor ligands
11/15/2011	US8058292 Therapeutic agents useful for treating pain
11/15/2011	US8058291 Methods and compositions for the treatment of CNS-related conditions
11/15/2011	US8058290 E.g., 1-[4-(3-amino-1H-pyrazolo[3,4-b]pyridin-6-yl)phenyl]-3-(2-fluoro-5-trifluoromethylphenyl)urea; and N-(6-{4-[3-(2-fluoro-5-trifluoromethylphenyl)ureido]-phenyl}-1H-pyrazolo[3,4-b]pyridin-3-yl))thiophene-3-carboxamide; kinase inhibitors, anticancer agents
11/15/2011	US8058289 Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors
11/15/2011	US8058288 Amido compounds and their use as pharmaceuticals
11/15/2011	US8058287 Chemokine receptor antagonists and methods of use therefor
11/15/2011	US8058285 Phosphodiesterase-4 (PDE-4) inhibitors; for treating bronchial asthma, COPD, rheumatoid arthritis (RA), osteoarthritis, cystic fibrosis, Guillain-Barresyndrome, Crohn's disease, ulcerative colitis, psoriasis, atopic dermatitis, allergic eczemas
11/15/2011	US8058284 [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto

1 ... 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 ... 7860